Balyasny Asset Management’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-200,000
Closed -$16K 2669
2023
Q1
$16K Sell
200,000
-68,055
-25% -$8.04K ﹤0.01% 2463
2022
Q4
$37.5K Sell
268,055
-68,243
-20% -$35.5K ﹤0.01% 2388
2022
Q3
$248K Sell
336,298
-183,085
-35% -$131K ﹤0.01% 2254
2022
Q2
$229K Sell
519,383
-43,330
-8% -$51.2K ﹤0.01% 2167
2022
Q1
$900K Sell
562,713
-3,953
-0.7% -$3.86K ﹤0.01% 1672
2021
Q4
$595K Hold
566,666
﹤0.01% 1585
2021
Q3
$499K Hold
566,666
﹤0.01% 1481
2021
Q2
$788K Buy
+566,666
New +$577K ﹤0.01% 1391

Other funds holding PIIIW

Balyasny Asset Management's PIIIW Position: Q2 2023 in Review

Balyasny Asset Management sold out of P3 Health Partners Inc Warrant (PIIIW) in Q2 2023, closing a stake of 200,000 shares — an estimated $16K sold.

Balyasny Asset Management first reported a position in PIIIW in Q2 2021 and held it in 8 quarters. The position peaked at $900K in Q1 2022. 22 funds tracked by Wall St. Rank hold PIIIW as of Q2 2023.

  • Balyasny Asset Management reported no remaining P3 Health Partners Inc Warrant position as of Q2 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 200,000 P3 Health Partners Inc Warrant shares in Q2 2023, an estimated $16K.
  • Balyasny Asset Management first reported a position in P3 Health Partners Inc Warrant in Q2 2021 and held it in 8 quarters.
  • Balyasny Asset Management's P3 Health Partners Inc Warrant position peaked at $900K in Q1 2022.
  • 22 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.